Filing Details
- Accession Number:
- 0001562180-19-005055
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-10-02 16:20:42
- Reporting Period:
- 2019-09-30
- Accepted Time:
- 2019-10-02 16:20:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1685071 | Dova Pharmaceuticals Inc. | DOVA | Pharmaceutical Preparations (2834) | 813858961 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1709417 | Kevin Laliberte | C/O Dova Pharmaceuticals, Inc. 240 Leigh Farm Road, Suite 245 Durham NC 27707 | Sr. Vp, Product Development | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-09-30 | 3,100 | $28.00 | 5,357 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-09-30 | 596 | $28.00 | 4,761 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan based on a limit price order adopted by the Reporting Person.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person with the intent to cover withholding taxes in connection with the settlement of restricted stock units.
Billionaire Hedge Funds
